@article{
author = "Kovačević, Milena and Catić-Đorđević, Aleksandra and Jovanović, Marija and Ćulafić, Milica and Stefanović, Nikola and Mitić, Branka and Vučićević, Katarina and Vezmar-Kovačević, Sandra and Veličković-Radovanović, Radmila and Miljković, Branislava",
year = "2024",
abstract = "The increasing number of multimorbid patients with complex drug regimens leads to a higher prevalence of inappropriate
prescribing with severe health issues and socioeconomic outcomes. The study aimed to compare the prevalence, types and
factors associated with the STOPP/START version 2 criteria across the inpatient, outpatient and community settings. An
observational study comprised 240 inpatients, 200 outpatients and 440 patients attending community pharmacies. At least one
STOPP criterion was present in 49 - 74.2% of patients, and the START prevalence ranged from 39.5 - 53.3%. The extent of
inappropriate prescribing was the lowest in the outpatients, followed by the community-dwelling patients, and the highest
among the inpatients. The most common STOPP criteria were drug indication (35.6%), followed by fall-risk drugs (32.3%),
central nervous system (28.3%), and cardiovascular system (11.7%). In almost one-third of outpatients (31.5%) and
community-dwelling patients (31.8%), up to 41.3% of inpatients, we found underprescribing cardiovascular system drugs. The
study revealed a high prevalence of STOPP/START v2 criteria across the inpatient, outpatient and community settings. The
highest frequency of inappropriate prescribing was observed during hospital stays when morbid and therapy states in elderly
patients become even more challenging. However, the observed increase in the prevalence of inappropriate prescribing during
hospitalisation indicates the opportunity to tailor the patient’s therapy in timely collaboration with specialists using up-to-date
clinical prescribing tools.",
publisher = "Societatea de Științe Farmaceutice din România",
journal = "Farmacia",
title = "Potentially inappropriate prescribing in elderly patients across healthcare settings: application of STOPP/START version 2 criteria",
volume = "72",
number = "3",
pages = "688-698",
doi = "10.31925/farmacia.2024.3.23"
}
